Sentinel Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,200
Closed -$331K 164
2021
Q4
$331K Buy
+1,200
New +$304K 0.04% 110
2019
Q1
Sell
-18,085
Closed -$2.09M 72
2018
Q4
$2.09M Sell
18,085
-16,992
-48% -$1.9M 0.65% 31
2018
Q3
$3.76M Sell
35,077
-1,295
-4% -$129K 0.82% 34
2018
Q2
$3.1M Sell
36,372
-6,985
-16% -$574K 0.69% 47
2018
Q1
$3.35M Buy
43,357
+21,675
+100% +$1.74M 0.71% 48
2017
Q4
$1.83M Buy
+21,682
New +$1.84M 0.38% 73
2015
Q3
Sell
-4,171
Closed -$348K 149
2015
Q2
$348K Sell
4,171
-575
-12% -$43.8K 0.09% 125
2015
Q1
$345K Sell
4,746
-30,410
-87% -$2.16M 0.09% 119
2014
Q4
$2.42M Sell
35,156
-1,002
-3% -$67.6K 0.69% 47
2014
Q3
$2.35M Sell
36,158
-250
-0.7% -$15.8K 0.6% 56
2014
Q2
$2.26M Buy
36,408
+335
+0.9% +$20K 0.59% 56
2014
Q1
$2.12M Sell
36,073
-11,400
-24% -$636K 0.59% 58
2013
Q4
$2.42M Sell
47,473
-93
-0.2% -$4.66K 0.67% 46
2013
Q3
$2.39M Buy
47,566
+16,322
+52% +$854K 0.72% 41
2013
Q2
$1.53M Buy
+31,244
New +$1.7M 0.46% 62

Other funds holding LLY

Sentinel Trust's LLY Position: Q1 2022 in Review

Sentinel Trust sold out of Eli Lilly (LLY) in Q1 2022, closing a stake of 1,200 shares — an estimated $331K sold.

Sentinel Trust first reported a position in LLY in Q2 2013 and held it in 15 quarters. The position peaked at $3.76M in Q3 2018. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Sentinel Trust reported no remaining Eli Lilly position as of Q1 2022 after selling out during the quarter.
  • Sentinel Trust sold 1,200 Eli Lilly shares in Q1 2022, an estimated $331K.
  • Sentinel Trust first reported a position in Eli Lilly in Q2 2013 and held it in 15 quarters.
  • Sentinel Trust's Eli Lilly position peaked at $3.76M in Q3 2018.
  • 2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Sentinel Trust's 13F filing for Q1 2022, filed 4 May 2022.